Biomedical, Clinical & Life Sciences

Since its inception, the NBF has awarded over $10 million to early-career investigators through its Scientific Research Grants Program. Many NBF early-career grant recipients have become leaders in the field. NBF awards grants for investigator-initiated original research in all aspects of blood banking, transfusion medicine, cellular therapies and patient blood management.

Areas of Interest
Immunology

Alloimmunization, immune modulation, and tolerance
Animal models for the study of graft-vs-host disease
Biology of autoimmune hemolytic anemia

Hematology

Autologous and allogeneic stem cell transplants
Detection of residual disease following stem cell transplants
Effects of growth factors in vitro and in vivo
Biochemistry of coagulation factors

Immunohematology

Blood group serology
Biochemistry of red cell antigens
Molecular genetics of the blood groups

Infectious Diseases

Studies on Lyme disease, West Nile Virus, SARS and babesiosis and other emerging diseases
Effect of allogeneic transfusion in HIV-infected and immunocompromised patients
Improved detection of transfusion - transmitted diseases

Cellular Therapies

Cell separation, cell culture or expansion studies for cell therapy applications
Development of novel cell therapies or assays to measure cell viability or function
Pilot studies in regenerative medicine
Studies on mechanisms or roles of cells in stem cell transplantation
Studies on cytokines or growth factors involved in stem cell differentiation

Patient Blood Management

Treatment of pre-admission anemia and bleeding tendencies; Intraoperative/postoperative blood recovery; Surgical hemostasis; Appropriate indications for transfusion; Changing physician behaviors; Blood utilization review.

Brain Research Foundation invites eligible US institutions to nominate one faculty member (Assistant or Associate Professor) to submit a Letter of Intent (LOI) for the BRF Seed Grant Program.

Brain Research Foundation’s Annual Seed Grant Program was initiated in 1981. The purpose of our program is to provide start-up monies for new research projects in the field of neuroscience that will likely lead to extramural funding from the National Institutes of Health (NIH) or other outside funding sources.

The objective of the BRF Seed Grant Program is to support new and innovative projects, especially those of junior faculty, who are working in new research directions. BRF Seed Grant awards are not intended to supplement existing grants.

Each total grant is limited to $80,000 (direct costs) for a two year grant period. The first grant payment of $40,000 will be made upon completion of the Seed Grant Acceptance Form (June 2024). The final payment of $40,000 will be made contingent upon receipt of a preliminary progress and financial report (June 2025). Funds must be utilized within the grant period.

Areas of Interest
1.) Funding is to be directed at pilot research projects that are both innovative and will likely lead to successful grant applications to NIH and other public and private funding entities.

2.) Assistant Professor – Junior faculty with a new research project that will generate pilot data that will lead to RO1 funding or a comparable outside grant will be first priority.

• Must provide abstract and specific aims for current grants and indicate if there is any overlap.

The objective of the AGA Research Foundation Research Scholar Award (RSA) is to support early-career investigators working toward independent and productive research careers in digestive diseases by ensuring that a major proportion of their time is protected for research (i.e., a minimum of 50 percent effort dedicated to the proposed project). The award will support junior faculty (not fellows) who have demonstrated exceptional promise and have some record of accomplishment in research.

The St. Baldrick's Foundation is a volunteer and donor powered charity committed to supporting the most promising research to find cures for childhood cancers and give survivors long and healthy lives.

The Scholar (Career Development) Award is meant to help develop the independent research of highly qualified individuals still early in their careers. Recipients are called St. Baldrick’s Scholars. (Up to $110,000/year, three-year minimum.)

Institutions may submit only one Scholar Award application per year.

The AASM Foundation is committed to developing the careers of sleep and circadian investigators by increasing support for sleep researchers. To meet this goal, the AASM Foundation has established research career development awards (CDA) to assist sleep researchers at various stages of their career.

The Bridge to Success for Early Career Investigators is an AASM Foundation CDA designed to provide ‘bridge’ funding to promising early career sleep and circadian scientists who have applied for a career development award such as a K-award grant from the National Institutes of Health (NIH), a CDA from the U.S. Department of Veterans Affairs (VA), or an equivalent career development grant from another federal or non-federal funding agency, but whose application was not within the funding range. Through this award, the AASM Foundation aims to assist investigators at a critical juncture in their career where bridge funding can determine whether a promising sleep and circadian scientist stays in the sleep field or moves to a different career track. The funding provides support during the period of time needed for revision and resubmission of a promising application in response to reviewer critiques.

The SFARI Bridge to Independence (BTI) program engages talented early-career scientists from diverse and/or historically underrepresented backgrounds to pursue research in autism and facilitates their transition into independent faculty positions at research institutions within or outside the U.S.

The program is aimed at Ph.D. and/or M.D.-holding scientists from diverse and/or historically underrepresented groups in science who are currently in a non-independent, mentored training position at an institution within or outside the U.S. and who will be actively seeking and applying to tenure-track faculty positions between September 2024–May 2025. Independence Fellows are expected to apply, secure and transition to a tenure-track faculty position at a research institution within or outside the U.S. by the end of the 2025–2026 academic year. U.S. citizenship or permanent resident status is not required. The BTI Award program welcomes applications that span the breadth of science that SFARI supports, including genetics, molecular mechanisms, circuits and systems, and clinical science.

Independence Fellows will receive up to two (2) years of postdoctoral fellowship support during their job search, with an annual salary of $85,000 USD, fringe benefits, an annual resource and professional development allowance of $10,000 USD, and indirect costs (see our grant policies) followed by a commitment of $600,000 USD over three (3) years, including indirect costs (see our grant policies), activated upon assumption of a tenure-track research professorship. The fellows will form a learning community and engage in professional development activities throughout their transition to research independence.

The McKnight Endowment Fund for Neuroscience (MEFN), an independent charitable organization established by The McKnight Foundation, was inspired by William L. McKnight’s personal interest in memory and its diseases. When Mr. McKnight (1887-1979) created the McKnight Foundation, he set aside part of his legacy to bring hope to those suffering from brain injury or disease and cognitive impairment. His descendants honor his commitment to neuroscience, and recognize that to continue the high level of excellence of the program the MEFN needs to incorporate diversity, equity, and inclusion in its award programs. To this end, the MEFN is expanding the number of annual Scholars awards from six to ten. The program will advance equity and drive innovation through inclusive excellence, recognizing that progress in neuroscience will be enhanced by the inclusion of new and diverse perspectives and voices.

The McKnight Scholar Awards are given to exceptional young scientists who are in the early stages of establishing an independent laboratory and research career. The intent of the program is to foster the commitment by these scientists to research careers that will have an important impact on the study of the brain. The program seeks to support scientists committed to mentoring neuroscientists from underrepresented groups at all levels of training. Applicants for the McKnight Scholar Award must demonstrate their ability to solve significant problems in neuroscience, which may include the translation of basic research to clinical practice. They should demonstrate a commitment to an equitable and inclusive lab environment.

The Young Investigator Award (YIA) provides funding to promising investigators to encourage and promote quality research in clinical oncology. The purpose of this grant is to fund physicians during the transition from a fellowship program to a faculty appointment. This is a mentored award and the research project is conducted under the guidance of a scientific mentor. Applications in all areas of cancer research are accepted from U.S. and international applicants.

The YIA is a one-year grant totaling $50,000 that supports personnel and/or research expenses, and travel to attend the Conquer Cancer Grants & Awards Ceremony at the ASCO Annual Meeting. Applicants who are selected to receive a YIA are allowed to receive other grants from other funding agencies.

The purpose of the NIDDK’s Division of Diabetes, Endocrinology and Metabolic Diseases (DDEMD) Administrative Supplement Program is to enable additional clinical perspectives to be brought to on-going research projects within the Division's mission and to enhance the research expertise of selected physicians.The program will provide supplementary funds to support advanced research opportunities for exceptional emerging physician-scientists (hereafter, "candidates") holding the MD or equivalent or MD/PhD degrees, and who are early in their research careers.

The supplement is intended to allow candidates to expand their research experience to help them transition beyond their clinical training to the next stage of their research careers as physician-scientists.

Administrative supplements must support work within the scope of a currently funded basic, behavioral, and/or clinical DDEMD research project. PIs of projects focused on type 1 diabetes are highly encouraged to apply given the limited numbers of new MD researchers entering this area. All applicants are strongly encouraged to discuss potential requests with the NIDDK DDEMD program director of the award for which they wish to submit a supplement application. See https://www.niddk.nih.gov/about-niddk/staff-directory/by-office/division-diabetes-endocrinology-metabolic-diseases for DDEMD program director contact information.

This Funding Opportunity Announcement (FOA) supports the Cancer Moonshot Scholars Diversity Program (CMSDP) and solicits R01 grant applications that propose independent research projects within the scientific mission of the National Cancer Institute (NCI). The overarching goal of the CMSDP is to increase the number of R01 Early Stage Investigators (ESIs) and enhance the diversity of the cancer research workforce, while promoting scientific advancements in cancer. Investigators from diverse backgrounds, including those from underrepresented groups (NOT-OD-20-031, Notice of NIH’s Interest in Diversity), are encouraged to work with their institutions to apply.